Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arya Biragyn

Showing results (1-10 of 83) with videos related to

Pageof 9
Sort By:
Current Protein & Peptide Science|January 11, 2005
Defensins--non-antibiotic use for vaccine developmentArya Biragyn
Haematologica|August 5, 2005
Rationale for dendritic cell-based vaccines for acute myeloid leukemiaArya Biragyn
Seminars in Cancer Biology|July 13, 2004
Cancer immunotherapy with chemoattractant peptidesMarta Coscia, Arya Biragyn
Expert Review of Vaccines|April 6, 2007
Clinical utilization of chemokines to combat cancer: the double-edged swordChiara Dell'Agnola, Arya Biragyn
The Lancet. Oncology|June 13, 2018
Gut dysbiosis: a potential link between increased cancer risk in ageing and inflammagingArya Biragyn, Luigi Ferrucci
Immunity & Ageing : I & A|January 5, 2021
Gut microbiota as the key controllers of "healthy" aging of elderly peopleEmeline Ragonnaud, Arya Biragyn
Seminars in Cancer Biology|January 20, 2012
Neoplastic "Black Ops": cancer's subversive tactics in overcoming host defensesArya Biragyn, Dan L Longo
Frontiers in Immunology|July 28, 2012
A new paradigm for an old story: the role of regulatory B cells in cancerArya Biragyn, Catalina Lee-Chang
Current Protocols in Immunology|April 25, 2008
Models for lymphomaArya Biragyn, Larry W Kwak
Seminars in Immunopathology|January 14, 2017
Potential importance of B cells in aging and aging-associated neurodegenerative diseasesArya Biragyn, Maria Aliseychik, Evgeny Rogaev
Pageof 9

Showing results (1-10 of 83) with videos related to

Sort By:
Pageof 9
Current Protein & Peptide Science|January 11, 2005
Defensins--non-antibiotic use for vaccine developmentArya Biragyn
Haematologica|August 5, 2005
Rationale for dendritic cell-based vaccines for acute myeloid leukemiaArya Biragyn
Seminars in Cancer Biology|July 13, 2004
Cancer immunotherapy with chemoattractant peptidesMarta Coscia, Arya Biragyn
Expert Review of Vaccines|April 6, 2007
Clinical utilization of chemokines to combat cancer: the double-edged swordChiara Dell'Agnola, Arya Biragyn
The Lancet. Oncology|June 13, 2018
Gut dysbiosis: a potential link between increased cancer risk in ageing and inflammagingArya Biragyn, Luigi Ferrucci
Immunity & Ageing : I & A|January 5, 2021
Gut microbiota as the key controllers of "healthy" aging of elderly peopleEmeline Ragonnaud, Arya Biragyn
Seminars in Cancer Biology|January 20, 2012
Neoplastic "Black Ops": cancer's subversive tactics in overcoming host defensesArya Biragyn, Dan L Longo
Frontiers in Immunology|July 28, 2012
A new paradigm for an old story: the role of regulatory B cells in cancerArya Biragyn, Catalina Lee-Chang
Current Protocols in Immunology|April 25, 2008
Models for lymphomaArya Biragyn, Larry W Kwak
Seminars in Immunopathology|January 14, 2017
Potential importance of B cells in aging and aging-associated neurodegenerative diseasesArya Biragyn, Maria Aliseychik, Evgeny Rogaev
Pageof 9